Mayo Clinic to hold trial for BrainStorm's ALS stem cell therapy

Posted on March 18th, 2013 by Logan Lafferty

BrainStorm Cell Therapeutics said the Mayo Clinic in Minnesota has agreed to conduct a clinical trial of the company's adult stem cell treatment for ALS. The Mayo Clinic is the third leading U.S. clinical site to sign a letter of understanding, following the University of Massachusetts and Massachusetts General, BrainStorm said on Monday.

Additional Coverage: Yahoo! News, Chicago Tribune



Tags: A.L.S., BrainStorm Cell Therapeutics, clinical trial, Industry News & Competitive Intelligence, Mayo Clinic Rochester, Research, Reuters, stem cell therapy, stem-cell

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy